Chronic Progressive External Ophthalmoplegia
Last Posted: Mar 10, 2023
- Outcome of epilepsy in patients with mitochondrial disorders: Phenotype genotype and magnetic resonance imaging correlations.
Bindu Parayil Sankaran, et al. Clinical neurology and neurosurgery 2017 0 182-189
- Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.
Morovat Alireza, et al. Journal of clinical medicine 2017 0 (8)
- Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China.
Hu Chaoping, et al. Frontiers in neurology 2020 0 1000
- [Chronic progressive external ophthalmoplegia that could not be diagnosed by biceps muscle biopsy, but was genetically diagnosed by extraocular muscle biopsy].
Shiraishi Wataru, et al. Rinsho shinkeigaku = Clinical neurology 2022 0 (12) 946-951
- Mitochondrial DNA maintenance disorders in 102 patients from different parts of Russia: Mutational spectrum and phenotypes.
Bychkov I O, et al. Mitochondrion 2021 0 205-212
- Disease impact in chronic progressive external ophthalmoplegia: more than meets the eye.
Smits Bart W, et al. Neuromuscular disorders : NMD 2011 0 (4) 272-8
- A retrospective cohort study exploring the association between different mitochondrial diseases and hearing loss.
van Kempen Carlijn M A, et al. Molecular genetics and metabolism 2022 0 (4) 333-341
- Genotypes of chronic progressive external ophthalmoplegia in a large adult-onset cohort.
Heighton Julia N, et al. Mitochondrion 2019 9
- Novel mutation in C10orf2 associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging.
Paramasivam Arumugam, et al. Mitochondrion 2015 12 81-85
- The unfolding clinical spectrum of POLG mutations.
Blok M J, et al. Journal of medical genetics 2009 11 (11) 776-85
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: